课题基金 / 基金详情

GINS4通过Snail拮抗p53乙酰化抑制肺腺癌铁死亡的机制研究

批准号:
82103229
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
陈玲
依托单位:
学科分类:
肿瘤细胞命运
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
陈玲

项目摘要

结项摘要

陈玲的其他基金

相似基金

相关文献

中文摘要
肺腺癌是肺癌最常见的病理类型,易侵袭转移。铁死亡是一种新型调节性细胞死亡模式。.具有EMT/侵袭特性的肿瘤对铁死亡敏感,然而其机制仍不清楚。我们前期工作表明,DNA复制分子GINS4在肺腺癌组织异常高表达,并促进肺腺癌细胞增殖和转移。基于此,本项目拟探讨GINS4通过上调EMT关键分子Snail,拮抗野生型p53乙酰化并促进其降解,从而抑制野生型p53对铁死亡的促进作用,促使肺腺癌发生发展。抑制GINS4的表达可增加G2/M期细胞对铁死亡的敏感性,从而遏制肺腺癌的侵袭与转移。.本课题将深入研究GINS4在肺腺癌中抑制铁死亡的生物学意义、GINS4通过Snail拮抗p53乙酰化的分子机制,以及探讨GINS4/Snail/p53这一通路在肺腺癌铁死亡中的重要作用,最终揭示GINS4在肺腺癌发生发展中的功能,有望为p53野生型和转移型肺腺癌的治疗提供理论依据。
英文摘要
Lung adenocarcinoma is the most common pathological type of lung cancer, which is prone to metastasis, and ferroptosis is a new type of programmed cell death. .Recently, it is reported that tumors with EMT and invasive characteristics are sensitive to ferroptosis. However, the mechanism of this phenomenon is still not clear. Our previous study showed that the GINS complex subunit 4 (GINS4), which is essential for DNA replication and cell cycle in eukaryotes, was highly expressed and could promote the proliferation and metastasis of lung adenocarcinoma cells. Based on this, our project intends to explore that GINS4 may up-regulate EMT key player Snail, thus inhibit acetylation of wild-type p53, promote its degradation, impair its promotion on ferroptosis, and ultimately promote survival and proliferation of lung adenocarcinoma cells. Besides,we found that inhibiting GINS4 expression in lung adenocarcinoma cells could promote sensitivity of G2/M phase cells to ferroptosis, and suppress invasion and metastasis of lung adenocarcinoma cells. .Our project will deeply research the biological significance of GINS4 suppressed ferroptosis in lung adenocarcinoma, the molecular mechanism of GINS4 antagonizing p53 acetylation through Snail, explore the important role of GINS4/snail/p53 pathway in ferroptosis of lung adenocarcinoma, and finally reveal the function of GINS4 in the occurrence and development of lung adenocarcinoma. It is expected to provide a theoretical basis for the treatment of wild-type p53 expressed and metastatic lung adenocarcinoma.
肺腺癌是肺癌最常见病理类型,易发生侵袭转移。铁死亡是一种新型调节性细胞死亡模式,可杀死肿瘤细胞,抑制肿瘤生长。通过本项目实施我们发现DNA复制分子GINS4在肺腺癌中高表达,促进肺腺癌进展;GINS4通过上调EMT关键分子Snail的活性,拮抗野生型p53乙酰化,降低p53活性,抑制肺腺癌细胞铁死亡,促使肺腺癌进展;此外,敲低GINS4,可增加细胞周期中G2/M期细胞对铁死亡诱导的敏感性。本课题将深入研究了GINS4在肺腺癌中抑制铁死亡的生物学意义,探讨了GINS4/Snail/p53这一通路在肺腺癌铁死亡中的重要作用。最终揭示GINS4在肺腺癌发生发展中的功能,有望为p53野生型和转移型肺腺癌的治疗提供理论依据。项目负责人以第一作者在PNAS、Autophagy杂志上发表论文2篇,其中PNAS入选2023年芙蓉实验室十大科技研究进展。以第一完成人获得2023年湖南省自然科学一等优秀学术论文。紧密关注国际前沿进展,参加中国细胞生物学会肿瘤细胞生物学分会并做会议报告、参加香港中文大学2024年肿瘤基础与转化研究进展学术研讨会。
靶向LSH相分离促进TAM铁死亡增强肺癌抗PD-1免疫应答的机制研究
  • 批准号:
    2025JJ50710
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2025
  • 负责人:
    陈玲
  • 依托单位:
DNA 复制分子GINS4通过HIF1α/Snail/p53抑制肺腺癌铁死亡
  • 批准号:
    2021JJ40804
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2021
  • 负责人:
    陈玲
  • 依托单位:
国内基金
海外基金